Do analysts rate JAGX or CNSP?

CNS Pharmaceuticals has a consensus target price of $20.00, indicating a potential upside of 366.74%. Given CNS Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe CNS Pharmaceuticals is more favorable than Jaguar Animal Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 CNS Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts prefer JAGX or BDRX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Biodexa Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, JAGX or BDRX?

Biodexa Pharmaceuticals has lower revenue, but higher earnings than Jaguar Animal Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Jaguar Animal Health $11.51M 0.16 -$53.43M -$591.92 N/A Biodexa Pharmaceuticals N/A N/A -$8.42M N/A N/A

Do analysts rate JAGX or GNPX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Genprex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is JAGX or GNPX more profitable?

Genprex has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. Genprex's return on equity of -247.32% beat Jaguar Animal Health's return on equity. Company Net Margins Return on Equity Return on Assets Jaguar Animal Health -169.04% -1,194.94% -115.55% Genprex N/A -247.32% -176.73%

Do analysts rate BCAB or JAGX?

BioAtla currently has a consensus price target of $200.00, indicating a potential upside of 4,955.61%. Given BioAtla's stronger consensus rating and higher possible upside, research analysts plainly believe BioAtla is more favorable than Jaguar Animal Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioAtla 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer JAGX or APVO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jaguar Animal Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Aptevo Therapeutics 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.33

Jaguar Animal Health (JAGX) Competitors

$2.98 +0.02 (+0.68%)

As of 11:47 AM Eastern

Compare

JAGX vs. CNSP, BDRX, GNPX, BCAB, and APVO

Should you buy Jaguar Animal Health stock or one of its competitors? MarketBeat compares Jaguar Animal Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Jaguar Animal Health include CNS Pharmaceuticals (CNSP), Biodexa Pharmaceuticals (BDRX), Genprex (GNPX), BioAtla (BCAB), and Aptevo Therapeutics (APVO). These companies are all part of the "pharmaceutical products" industry.

How does Jaguar Animal Health compare to CNS Pharmaceuticals?

Jaguar Animal Health (NASDAQ:JAGX) and CNS Pharmaceuticals (NASDAQ:CNSP) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership.

CNS Pharmaceuticals has lower revenue, but higher earnings than Jaguar Animal Health. CNS Pharmaceuticals is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$11.51M	0.16	-$53.43M	-$591.92	N/A
CNS Pharmaceuticals	N/A	N/A	-$15.85M	-$29.63	N/A

CNS Pharmaceuticals has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. CNS Pharmaceuticals' return on equity of -238.68% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-169.04%	-1,194.94%	-115.55%
CNS Pharmaceuticals	N/A	-238.68%	-166.30%

In the previous week, Jaguar Animal Health and Jaguar Animal Health both had 1 articles in the media. CNS Pharmaceuticals' average media sentiment score of 1.89 beat Jaguar Animal Health's score of 0.94 indicating that CNS Pharmaceuticals is being referred to more favorably in the news media.

Company	Overall Sentiment
Jaguar Animal Health	Positive
CNS Pharmaceuticals	Very Positive

CNS Pharmaceuticals has a consensus target price of $20.00, indicating a potential upside of 366.74%. Given CNS Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe CNS Pharmaceuticals is more favorable than Jaguar Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
CNS Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Jaguar Animal Health has a beta of -0.09, indicating that its share price is 109% less volatile than the broader market. Comparatively, CNS Pharmaceuticals has a beta of 3.05, indicating that its share price is 205% more volatile than the broader market.

12.0% of Jaguar Animal Health shares are held by institutional investors. Comparatively, 14.0% of CNS Pharmaceuticals shares are held by institutional investors. 2.0% of Jaguar Animal Health shares are held by insiders. Comparatively, 0.0% of CNS Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

CNS Pharmaceuticals beats Jaguar Animal Health on 10 of the 14 factors compared between the two stocks.

How does Jaguar Animal Health compare to Biodexa Pharmaceuticals?

Jaguar Animal Health (NASDAQ:JAGX) and Biodexa Pharmaceuticals (NASDAQ:BDRX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

Jaguar Animal Health has a beta of -0.09, indicating that its stock price is 109% less volatile than the broader market. Comparatively, Biodexa Pharmaceuticals has a beta of 1.23, indicating that its stock price is 23% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Biodexa Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Biodexa Pharmaceuticals has lower revenue, but higher earnings than Jaguar Animal Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$11.51M	0.16	-$53.43M	-$591.92	N/A
Biodexa Pharmaceuticals	N/A	N/A	-$8.42M	N/A	N/A

12.0% of Jaguar Animal Health shares are held by institutional investors. Comparatively, 17.5% of Biodexa Pharmaceuticals shares are held by institutional investors. 2.0% of Jaguar Animal Health shares are held by company insiders. Comparatively, 0.3% of Biodexa Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Biodexa Pharmaceuticals had 5 more articles in the media than Jaguar Animal Health. MarketBeat recorded 6 mentions for Biodexa Pharmaceuticals and 1 mentions for Jaguar Animal Health. Jaguar Animal Health's average media sentiment score of 0.94 beat Biodexa Pharmaceuticals' score of 0.50 indicating that Jaguar Animal Health is being referred to more favorably in the media.

Company	Overall Sentiment
Jaguar Animal Health	Positive
Biodexa Pharmaceuticals	Neutral

Biodexa Pharmaceuticals has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. Biodexa Pharmaceuticals' return on equity of 0.00% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-169.04%	-1,194.94%	-115.55%
Biodexa Pharmaceuticals	N/A	N/A	N/A

Summary

Biodexa Pharmaceuticals beats Jaguar Animal Health on 7 of the 10 factors compared between the two stocks.

How does Jaguar Animal Health compare to Genprex?

Jaguar Animal Health (NASDAQ:JAGX) and Genprex (NASDAQ:GNPX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

12.0% of Jaguar Animal Health shares are owned by institutional investors. Comparatively, 14.1% of Genprex shares are owned by institutional investors. 2.0% of Jaguar Animal Health shares are owned by company insiders. Comparatively, 0.3% of Genprex shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Genprex has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. Genprex's return on equity of -247.32% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-169.04%	-1,194.94%	-115.55%
Genprex	N/A	-247.32%	-176.73%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Genprex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Genprex has lower revenue, but higher earnings than Jaguar Animal Health. Genprex is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$11.51M	0.16	-$53.43M	-$591.92	N/A
Genprex	N/A	N/A	-$16.23M	-$14.14	N/A

Jaguar Animal Health has a beta of -0.09, indicating that its stock price is 109% less volatile than the broader market. Comparatively, Genprex has a beta of -0.98, indicating that its stock price is 198% less volatile than the broader market.

In the previous week, Jaguar Animal Health and Jaguar Animal Health both had 1 articles in the media. Genprex's average media sentiment score of 1.89 beat Jaguar Animal Health's score of 0.94 indicating that Genprex is being referred to more favorably in the news media.

Company	Overall Sentiment
Jaguar Animal Health	Positive
Genprex	Very Positive

Summary

Genprex beats Jaguar Animal Health on 6 of the 11 factors compared between the two stocks.

How does Jaguar Animal Health compare to BioAtla?

BioAtla (NASDAQ:BCAB) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, risk, profitability, institutional ownership and earnings.

BioAtla has a beta of 0.79, meaning that its share price is 21% less volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of -0.09, meaning that its share price is 109% less volatile than the broader market.

BioAtla currently has a consensus price target of $200.00, indicating a potential upside of 4,955.61%. Given BioAtla's stronger consensus rating and higher possible upside, research analysts plainly believe BioAtla is more favorable than Jaguar Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioAtla	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

77.2% of BioAtla shares are owned by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are owned by institutional investors. 9.3% of BioAtla shares are owned by insiders. Comparatively, 2.0% of Jaguar Animal Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

BioAtla has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. BioAtla's return on equity of 0.00% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BioAtla	N/A	N/A	-325.64%
Jaguar Animal Health	-169.04%	-1,194.94%	-115.55%

In the previous week, BioAtla and BioAtla both had 1 articles in the media. BioAtla's average media sentiment score of 1.87 beat Jaguar Animal Health's score of 0.94 indicating that BioAtla is being referred to more favorably in the media.

Company	Overall Sentiment
BioAtla	Very Positive
Jaguar Animal Health	Positive

Jaguar Animal Health has higher revenue and earnings than BioAtla. BioAtla is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioAtla	$2M	3.28	-$59.61M	-$41.72	N/A
Jaguar Animal Health	$11.51M	0.16	-$53.43M	-$591.92	N/A

Summary

BioAtla beats Jaguar Animal Health on 11 of the 15 factors compared between the two stocks.

How does Jaguar Animal Health compare to Aptevo Therapeutics?

Jaguar Animal Health (NASDAQ:JAGX) and Aptevo Therapeutics (NASDAQ:APVO) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

In the previous week, Jaguar Animal Health and Jaguar Animal Health both had 1 articles in the media. Aptevo Therapeutics' average media sentiment score of 1.89 beat Jaguar Animal Health's score of 0.94 indicating that Aptevo Therapeutics is being referred to more favorably in the news media.

Company	Overall Sentiment
Jaguar Animal Health	Positive
Aptevo Therapeutics	Very Positive

Aptevo Therapeutics has lower revenue, but higher earnings than Jaguar Animal Health. Aptevo Therapeutics is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$11.51M	0.16	-$53.43M	-$591.92	N/A
Aptevo Therapeutics	N/A	N/A	-$25.97M	-$197.60	N/A

12.0% of Jaguar Animal Health shares are held by institutional investors. Comparatively, 8.1% of Aptevo Therapeutics shares are held by institutional investors. 2.0% of Jaguar Animal Health shares are held by company insiders. Comparatively, 0.1% of Aptevo Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Aptevo Therapeutics	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

Aptevo Therapeutics has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -169.04%. Aptevo Therapeutics' return on equity of -198.50% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-169.04%	-1,194.94%	-115.55%
Aptevo Therapeutics	N/A	-198.50%	-117.06%

Jaguar Animal Health has a beta of -0.09, indicating that its share price is 109% less volatile than the broader market. Comparatively, Aptevo Therapeutics has a beta of 1.68, indicating that its share price is 68% more volatile than the broader market.

Summary

Aptevo Therapeutics beats Jaguar Animal Health on 8 of the 13 factors compared between the two stocks.

Get Jaguar Animal Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JAGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

JAGX vs. The Competition

Export

Metric	Jaguar Animal Health	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.79M	$3.04B	$6.76B	$12.51B
Dividend Yield	N/A	1.87%	2.66%	6.22%
P/E Ratio	-0.01	19.59	25.78	24.73
Price / Sales	0.16	361.90	548.02	103.35
Price / Cash	N/A	56.85	29.14	36.96
Price / Book	-0.03	4.27	10.84	6.52
Net Income	-$53.43M	$64.45M	$3.57B	$336.86M
7 Day Performance	16.41%	3.08%	2.43%	1.31%
1 Month Performance	-16.06%	3.79%	0.76%	0.36%
1 Year Performance	-96.62%	34.58%	36.68%	30.89%

Jaguar Animal Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
JAGX Jaguar Animal Health	0.3863 of 5 stars	$2.98 +0.7%	N/A	-96.6%	$1.79M	$11.51M	N/A	50	News Coverage
CNSP CNS Pharmaceuticals	3.9266 of 5 stars	$4.29 +0.2%	$20.00 +366.2%	-60.7%	$6.26M	N/A	N/A	5
BDRX Biodexa Pharmaceuticals	0.9097 of 5 stars	$2.78 -7.6%	N/A	-93.4%	$6.01M	$470K	N/A	20	News Coverage Analyst Revision
GNPX Genprex	0.8633 of 5 stars	$0.52 -5.3%	N/A	-95.4%	$6.01M	N/A	N/A	20	Positive News
BCAB BioAtla	2.2 of 5 stars	$3.57 -1.4%	$200.00 +5,502.2%	-80.1%	$6M	$2M	N/A	60

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:JAGX) was last updated on 6/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Jaguar Animal Health (JAGX) Competitors

JAGX vs. CNSP, BDRX, GNPX, BCAB, and APVO

How does Jaguar Animal Health compare to CNS Pharmaceuticals?

Summary

How does Jaguar Animal Health compare to Biodexa Pharmaceuticals?

Summary

How does Jaguar Animal Health compare to Genprex?

Summary

How does Jaguar Animal Health compare to BioAtla?

Summary

How does Jaguar Animal Health compare to Aptevo Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JAGX vs. The Competition

Jaguar Animal Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Jaguar Animal Health (JAGX) Competitors

JAGX vs. CNSP, BDRX, GNPX, BCAB, and APVO

How does Jaguar Animal Health compare to CNS Pharmaceuticals?

Which has stronger earnings & valuation, JAGX or CNSP?

Is JAGX or CNSP more profitable?

Does the media prefer JAGX or CNSP?

Do analysts rate JAGX or CNSP?

Which has more volatility & risk, JAGX or CNSP?

Do institutionals & insiders hold more shares of JAGX or CNSP?

Summary

How does Jaguar Animal Health compare to Biodexa Pharmaceuticals?

Which has more risk & volatility, JAGX or BDRX?

Do analysts prefer JAGX or BDRX?

Which has better earnings and valuation, JAGX or BDRX?

Do insiders and institutionals believe in JAGX or BDRX?

Does the media refer more to JAGX or BDRX?

Is JAGX or BDRX more profitable?

Summary

How does Jaguar Animal Health compare to Genprex?

Do insiders & institutionals hold more shares of JAGX or GNPX?

Is JAGX or GNPX more profitable?

Do analysts rate JAGX or GNPX?

Which has stronger earnings and valuation, JAGX or GNPX?

Which has more risk and volatility, JAGX or GNPX?

Does the media favor JAGX or GNPX?

Summary

How does Jaguar Animal Health compare to BioAtla?

Which has more volatility & risk, BCAB or JAGX?

Do analysts rate BCAB or JAGX?

Do institutionals & insiders hold more shares of BCAB or JAGX?

Is BCAB or JAGX more profitable?

Does the media prefer BCAB or JAGX?

Which has better earnings and valuation, BCAB or JAGX?

Summary

How does Jaguar Animal Health compare to Aptevo Therapeutics?

Does the media prefer JAGX or APVO?

Which has preferable earnings and valuation, JAGX or APVO?

Do insiders & institutionals hold more shares of JAGX or APVO?

Do analysts prefer JAGX or APVO?

Is JAGX or APVO more profitable?

Which has more risk & volatility, JAGX or APVO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JAGX vs. The Competition

Jaguar Animal Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools